Latest news with #IndiraIVFHospital
Time of India
6 days ago
- Business
- Time of India
Indira IVF Hospital files for IPO via confidential route, newspaper ad shows
Bengaluru: Indian fertility services provider Indira IVF Hospital has filed draft papers confidentially with the country's markets regulator for an initial public offering , a newspaper advertisement showed on Wednesday. The offering could be worth around 35 billion rupees ($407.2 million), Bloomberg News reported on Tuesday, citing people familiar with the matter. The deal will not include the issuance of new shares as existing shareholders will offload their stakes, the report said. The company, backed by Hong Kong-based investment firm BPEA EQT , had filed for the IPO in February. However, it later withdrew its draft documents in March after the release of a Bollywood biopic about the company's founder raised concerns with the Securities and Exchange Board of India , the markets regulator, according to The Economic Times, a business daily. The confidential route allows companies to submit draft IPO papers to SEBI for feedback without making the details public, giving them greater flexibility on timing and disclosure. Indira IVF Hospital did not immediately respond to a Reuters request for comment.
Economic Times
6 days ago
- Business
- Economic Times
Indira IVF IPO: EQT-backed fertility clinic chain refiles draft papers with Sebi via confidential route
Fertility chain Indira IVF has refiled its Draft Red Herring Prospectus (DRHP) through the confidential filing route, reviving its public listing plans, according to sources. Tired of too many ads? Remove Ads Tired of too many ads? Remove Ads Fertility chain Indira IVF has refiled its Draft Red Herring Prospectus (DRHP) through the confidential filing route, reviving its public listing plans, according to move comes amidst growing investor interest in the Indian assisted reproductive technology (ART) sector, buoyed by increasing awareness, expanding market size, and favorable people familiar with the matter, Bloomberg on Tuesday had reported that Indira IVF Hospital will soon submit preliminary documents for a listing that may fetch Rs 3,500 crore ($408 million).The company is backed by private equity firm EQT AB. The deal won't involve the issue of new stock as existing shareholders will be selling their holdings, the report said, quoting the will probably offload 29 billion rupees of shares in the offering, and three members of the founding family — Ajay Murdia, Kshitiz Murdia and Nitiz Murdia — will each sell shares worth 2 billion rupees, the people company had initially submitted a draft prospectus in February but withdrew it in March. The withdrawal came as the IPO plans coincided with the release of a Bollywood biopic based on the company's founder, which drew concerns from the Securities and Exchange Board of developments signal renewed IPO momentum in India's fertility and women's health segment, with investors closely watching how these companies position themselves in a competitive and rapidly evolving healthcare Mahindra Capital Co., IIFL Capital Services Ltd. , JPMorgan Chase & Co. and UBS Group AG are advising on the as per sources, Gaudium IVF and Women Health, another prominent player in the fertility care space, is also preparing to refile its DRHP in the immediate future, as part of its continued efforts to tap into capital markets and fuel its next phase of growth.
New Straits Times
7 days ago
- Business
- New Straits Times
India's Indira IVF Hospital files for IPO via confidential route
KUALA LUMPUR: Indian fertility services provider Indira IVF Hospital has filed draft papers confidentially with the country's markets regulator for an initial public offering, a newspaper advertisement showed on Wednesday. The offering could be worth around 35 billion rupees (US$407.2 million), Bloomberg News reported on Tuesday, citing people familiar with the matter. The deal will not include the issuance of new shares as existing shareholders will offload their stakes, the report said. The company, backed by Hong Kong-based investment firm BPEA EQT, had filed for the IPO in February. However, it later withdrew its draft documents in March after the release of a Bollywood biopic about the company's founder raised concerns with the Securities and Exchange Board of India, the markets regulator, according to The Economic Times, a business daily. The confidential route allows companies to submit draft IPO papers to SEBI for feedback without making the details public, giving them greater flexibility on timing and disclosure.
&w=3840&q=100)
Business Standard
7 days ago
- Business
- Business Standard
Indira IVF's $408 million India IPO may see EQT, founders exit stake
Indira IVF Hospital is reviving its initial public offering plans in India and will soon submit preliminary documents for a listing that may fetch Rs 35 billion ($408 million), according to people familiar with the matter. The company, backed by private equity firm EQT AB, plans to submit the so-called draft red herring prospectus later this month, according to the people, who asked not to be identified discussing a private matter. The deal won't involve the issue of new stock as existing shareholders will be selling their holdings, the people said. EQT will probably offload 29 billion rupees of shares in the offering, and three members of the founding family — Ajay Murdia, Kshitiz Murdia and Nitiz Murdia — will each sell shares worth Rs 2 billion, the people said. A spokesperson of the company didn't immediately respond to an email seeking comment. The company had initially submitted a draft prospectus in February but withdrew it in March. The withdrawal came as the IPO plans coincided with the release of a Bollywood biopic based on the company's founder, which drew concerns from the Securities and Exchange Board of India, according to the Economic Times. Founded in 2011, Indira IVF operates more than 155 fertility centers and works with 315 IVF specialists across India as of September 2024, according to a previously filed preliminary prospectus. Kotak Mahindra Capital Co., IIFL Capital Services Ltd., JPMorgan Chase & Co. and UBS Group AG are advising on the IPO.
Mint
15-07-2025
- Business
- Mint
Indira IVF looks to revive IPO plans to raise ₹3500 crore: Report
Indira IVF Hospital is reviving its initial public offering plans in India and will soon submit preliminary documents for a listing that may fetch 35 billion rupees ($408 million), according to people familiar with the matter. The company, backed by private equity firm EQT AB, plans to submit the so-called draft red herring prospectus later this month, according to the people, who asked not to be identified discussing a private matter. The deal won't involve the issue of new stock as existing shareholders will be selling their holdings, the people said. EQT will probably offload 29 billion rupees of shares in the offering, and three members of the founding family — Ajay Murdia, Kshitiz Murdia and Nitiz Murdia — will each sell shares worth 2 billion rupees, the people said. A spokesperson of the company didn't immediately respond to an email seeking comment. The company had initially submitted a draft prospectus in February but withdrew it in March. The withdrawal came as the IPO plans coincided with the release of a Bollywood biopic based on the company's founder, which drew concerns from the Securities and Exchange Board of India, according to the Economic Times. Founded in 2011, Indira IVF operates more than 155 fertility centers and works with 315 IVF specialists across India as of September 2024, according to a previously filed preliminary prospectus.
